"Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration for Colesevelam Hydrochloride tablets, 625 mg," the company said in a BSE filing today.
For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory
No comments:
Post a Comment